Bristol Myers on Friday said the European Medicines Agency's Committee for Medicinal Products for Human Use recommended approval of Breyanzi for the treatment of adults with relapsed or refractory ...
PRINCETON, N.J. - Bristol Myers Squibb (NYSE: BMY), a prominent pharmaceutical company with a market capitalization of nearly $120 billion and impressive gross profit margins of 76%, received a ...
What if Aaron Rodgers came out of his darkness retreat and retired in 2023? This is what may have happened to the New York ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback